Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Cash & Current Investments (2019 - 2025)

P3 Health Partners (PIII) has disclosed Cash & Current Investments for 7 consecutive years, with $37.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Current Investments fell 44.62% year-over-year to $37.7 million, compared with a TTM value of $37.7 million through Sep 2025, down 44.62%, and an annual FY2024 reading of $44.1 million, changed N/A over the prior year.
  • Cash & Current Investments was $37.7 million for Q3 2025 at P3 Health Partners, down from $39.3 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $110.7 million in Q1 2022 and bottomed at $1.2 million in Q1 2023.
  • Average Cash & Current Investments over 5 years is $32.2 million, with a median of $29.2 million recorded in 2021.
  • The sharpest move saw Cash & Current Investments plummeted 98.93% in 2023, then skyrocketed 2614.71% in 2024.
  • Year by year, Cash & Current Investments stood at $5.4 million in 2021, then surged by 243.98% to $18.4 million in 2022, then tumbled by 73.52% to $4.9 million in 2023, then soared by 804.1% to $44.1 million in 2024, then dropped by 14.48% to $37.7 million in 2025.
  • Business Quant data shows Cash & Current Investments for PIII at $37.7 million in Q3 2025, $39.3 million in Q2 2025, and $1.2 million in Q1 2025.